هزینه مقرون به صرفه واکسن واریسلا در برابر هرپس زوستر و نورالژی پس از هرپس برای سالمندان در ژاپن

We found that vaccinating individuals aged 65–84, 70–84, 75–84, and 80–84 with varicella vaccine to prevent HZ-associated disease in Japan can be cost-effective from societal perspective, with 65–84 y.o. strategy as the optimal alternative. Results are supported by one-way sensitivity analyses and probabilistic sensitivity analyses.